[Walmart, Eli Lilly, and Others Oppose OKXICE Tokenized Stock Plan, Total Number of Opposing Companies Rises to 38] BlockBeats reported on October 29th that Walmart, Eli Lilly, Carnival, Arcos Dorados, and Cigna have joined the list of companies opposing the OKXICE tokenized stock trading plan, a joint venture between OKX and Intercontinental Exchange (ICE), the parent company of the NYSE. An updated announcement shows that the number of companies disclosing their opposition has reached 38, exceeding half of the original proposed list of 62. The plan relies on the SEC's "Innovation Exemption" framework. When shares are tokenized by an unrelated third party, the exchange must notify the issuer and grant a 30-day objection period. If no objection is expressed, the transaction can proceed, and there is no mechanism for withdrawing consent afterward. JPMorgan Chase has also opposed the plan; a spokesperson stated that they are not involved at this stage but do not rule out future opportunities. [Original Link]